2012
DOI: 10.1038/jcbfm.2012.32
|View full text |Cite
|
Sign up to set email alerts
|

Novel Mitochondrial Targets for Neuroprotection

Abstract: Mitochondrial dysfunction contributes to the pathophysiology of acute neurologic disorders and neurodegenerative diseases. Bioenergetic failure is the primary cause of acute neuronal necrosis, and involves excitotoxicity-associated mitochondrial Ca 2 + overload, resulting in opening of the inner membrane permeability transition pore and inhibition of oxidative phosphorylation. Mitochondrial energy metabolism is also very sensitive to inhibition by reactive O 2 and nitrogen species, which modify many mitochondr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
108
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 125 publications
(111 citation statements)
references
References 126 publications
3
108
0
Order By: Relevance
“…4 Pharmacologic approaches toward minimizing abnormal alterations in mitochondrial dynamics warrant exploration and might exert neuroprotection beyond what has been observed with inhibitors of the mitochondrial permeability transition that help maintain mitochondrial and cellular integrity. 66 Our data suggest that TBI therapeutic interventions might target mitochondria in Far and Penumbral zones to protect and preserve potentially viable cortical tissue. In contrast to Near zone, these zones appear to exhibit high levels of reversibly altered mitochondria within the first few days to 1 week post-injury, depending on the severity (GCS) of the injury.…”
Section: Discussionmentioning
confidence: 99%
“…4 Pharmacologic approaches toward minimizing abnormal alterations in mitochondrial dynamics warrant exploration and might exert neuroprotection beyond what has been observed with inhibitors of the mitochondrial permeability transition that help maintain mitochondrial and cellular integrity. 66 Our data suggest that TBI therapeutic interventions might target mitochondria in Far and Penumbral zones to protect and preserve potentially viable cortical tissue. In contrast to Near zone, these zones appear to exhibit high levels of reversibly altered mitochondria within the first few days to 1 week post-injury, depending on the severity (GCS) of the injury.…”
Section: Discussionmentioning
confidence: 99%
“…Assessment of phospholipids, monolysophospholipids, and CL oxidation was performed by liquid chromatography-mass spectrometry (LC-MS) utilizing Dionex HPLC system coupled to a LXQTM ion trap MS or to a hybrid quadrupole-orbitrap mass spectrometer, Q-Exactive (ThermoFisher, Inc., San Jose, CA, USA) as described previously. [14][15][16] For additional detailed analysis of CL and monolyso-CL, normal phase column Luna 3 μm Silica (2) 100 Å column (Phenomenex, Torrance, CA, USA) and gradient solvent A (hexane/propanol/water, 47:57:1, v/v) and solvent B (hexane/propanol/ water, 47:57:10, v/v) each containing 5 mmol/L ammonium acetate and 0.01% formic acid was used. The column was eluted at a flow rate of 0.05 mL/min as follows; 0 to 3 minutes, linear gradient,10% to 37% solvent B; 3 to 12.5 minutes, isocratic at 37% solvent B; 12.5 to 20 minutes, linear gradient, 37% to 100% solvent B; 20 to 45 minutes, isocratic at 100% solvent B; 45 to 60 minutes, isocratic at 10% solvent B.…”
Section: Cardiac Arrest Modelmentioning
confidence: 99%
“…The binding properties of 18 F-BCPP-EF were assessed in an ischemic brain model of living monkey using high-resolution PET, and its cerebral uptake was compared with the regional cerebral blood flow (rCBF), regional cerebral metabolism of oxygen (rCMRO 2 ) measured with 15 O-gases, 11 C-flumazenil ( 11 C-FMZ) binding to the central-type benzodiazepine receptor (CBR), 11 C-PBR28 binding to the translocator protein, and regional cerebral blood flow (rCMRglc) measured with 18 F-FDG at Day-7/8 after 3-hour MCAO ischemic insult in the monkey brain.…”
Section: Introductionmentioning
confidence: 99%